Teladoc Health and Dexcom Bring CGM Technology and Personalized Insights to People with Type 2 Diabetes at No Cost

Rhea-AI Summary

Teladoc Health and DexCom announced a partnership to enhance diabetes management for Type 2 diabetes patients. Joint members of Livongo for Diabetes will receive new CGM-powered insights that integrate Dexcom’s continuous glucose monitoring data with additional health signals from Teladoc. This offering aims to empower users with actionable health recommendations and will be piloted at no cost to eligible members in 2021. The collaboration highlights a rising trend in diabetes, with estimates suggesting 463 million adults currently affected globally.

Positive

• Launch of CGM-powered insights enhances diabetes management.
• Pilot program offered at no cost to eligible Livongo for Diabetes members.
• Collaboration expected to improve consumer health outcomes.

Negative

• None

New offering measures the impact of continuous glucose monitoring and real-time health recommendations for people with Type 2 diabetes

PURCHASE, NY and SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the first and only comprehensive virtual care system, and DexCom, Inc., the leader in real-time continuous glucose monitoring (CGM), today announced that joint Livongo for Diabetes and Dexcom members will now receive CGM-powered insights, a new set of features and reports that help members more easily visualize their health information and understand how lifestyle decisions affect their blood glucose levels. By combining Dexcom CGM data with additional signals from Teladoc Health, including activity data and food intake, CGM-powered insights offer members a complete health profile and recommendations that support ongoing diabetes management. In January of 2020, Livongo, which merged with Teladoc Health in October, and Dexcom announced the first phase of their strategic relationship, a data sharing agreement for Livongo for Diabetes members using Dexcom CGM technology.

“Teladoc Health’s partnership with Dexcom further empowers whole person health through an innovative combination of advanced technology and human expertise,” said Amar Kendale, chief product officer of Teladoc Health. “Our focus is to offer a consumer experience that makes it easy, safe and affordable for people to manage their health with confidence. We are excited about our continued work with Dexcom and new features that enable smarter care, leading to measurable consumer behavior change and better health outcomes.”

To that end, Teladoc Health and Dexcom will launch a pilot demonstrating the impact of CGM-powered insights for people with Type 2 diabetes. Eligible members will receive an integrated product experience, including the Livongo for Diabetes program, Dexcom CGM technology and CGM-powered insights at no cost. Through the pilot, members will access a new experience that contextualizes their health data and trends with the mutual goal of better health outcomes. Teladoc Health and Dexcom intend to launch the pilot more broadly throughout 2021.

“We are excited to announce the next phase of our relationship with Teladoc Health, along with launching a commercial pilot demonstrating how Dexcom’s leading CGM combined with Teladoc Health’s data science capabilities enhance the diabetes management experience,” said Matt Dolan, senior vice president and general manager of new markets for Dexcom. “We have received powerful feedback from people with Type 2 diabetes using our technology, and through additional innovative product features, we fully anticipate that we will deliver an even greater impact.”

It is estimated that 463 million adults around the world live with diabetes¹, a number expected to rise to 700 million by 2045. According to the Centers for Disease Control and Prevention, regular physical activity, weight management, and improved blood pressure management are important factors for preventing diabetes-related complications².

About Teladoc Health

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.

Teladoc Health Media Contact:

Jake Mazanke
pr@teladochealth.com
630-640-5253

Teladoc Health Investor Contact:

Patrick Feeley
pfeeley@teladochealth.com
914-265-7925

---

¹  IDF Diabetes Atlas Ninth edition 2019 
² CDC National Diabetes Statistic Report 2020, Estimated Diabetes and its Burden on the United States 

FAQ

What is the partnership between Teladoc and DexCom?

Teladoc and DexCom partnered to provide CGM-powered insights for better diabetes management, integrating health data for Type 2 diabetes patients.

When is the pilot program for CGM-powered insights launching?

The pilot program is set to launch in 2021 for eligible members of Livongo for Diabetes.

How will CGM-powered insights benefit Type 2 diabetes patients?

The insights will help patients visualize health information and understand how lifestyle choices affect their blood glucose levels.

What are the expectations for the impact of CGM-powered insights?

The insights are anticipated to lead to measurable changes in consumer behavior and improved health outcomes.

How many adults currently live with diabetes globally?

Approximately 463 million adults globally are affected by diabetes, a number projected to rise to 700 million by 2045.